| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 08/13/2009 | US20090202431 Stem-like cells in bone sarcomas |
| 08/13/2009 | US20090202430 Composition for cytocompatible, injectable, self-gelling polysaccharide solutions for encapsulating and delivering live cells or biologically active factors |
| 08/13/2009 | US20090202429 Methods for testing anti-thrombotic agents |
| 08/13/2009 | US20090202428 Use of Dtbz for Imaging Endocrine Pancreas and Beta Cell Mass In Type 1 Diabetes |
| 08/12/2009 | EP2087891A2 Pharmaceutical compositions for treating lymphoma |
| 08/12/2009 | EP2087103A1 Cancerous disease modifying antibodies |
| 08/12/2009 | EP2086924A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation |
| 08/12/2009 | EP2086592A2 Weakly basic 2- nitroimidazoles for the non-invasive detection of tissue hypoxia |
| 08/12/2009 | EP2086506A2 Preparation of heavy metal-containing nano-liposomes and their uses in medical therapy |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | CN101505803A Composition for diagnosing amyloid-related disease |
| 08/12/2009 | CN101504361A Method for marking calcium warehouse in animal body and its article production method |
| 08/11/2009 | US7572765 polypeptides or fragments used for treating bone disorders such as osteoporosis |
| 08/11/2009 | US7572598 Preparation comprising albumin esterified with a labeled substance for diagnosis of pancreatic exocrine function |
| 08/11/2009 | US7572444 Binding proteins specific for human matriptase |
| 08/11/2009 | CA2408535C Compositions comprising dendrimer complexes |
| 08/11/2009 | CA2258503C Lectin compositions and uses thereof |
| 08/06/2009 | WO2009094752A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009094751A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009094741A1 Radiopharmaceuticaldrug and pharmaceutical composition for treatment and diagnosis of cancer |
| 08/06/2009 | WO2008091530A3 Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
| 08/06/2009 | WO2008083191A3 Radiofluorination methods |
| 08/06/2009 | US20090197342 measuring the level of pregnancy-associated plasma protein-A (PAPP-A) in a biological sample from a non-pregnant patient and comparing the level with that of control subjects |
| 08/05/2009 | EP2085095A1 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart |
| 08/05/2009 | EP2083871A2 A system for determining a distribution of radioactive agents in a subject |
| 08/05/2009 | EP1706155A4 Polymeric micellar complexes and drug delivery vehicles thereof |
| 08/05/2009 | EP1670519A4 Radiolabeled thymidine solid-phase extraction purification method |
| 08/05/2009 | CN201283163Y Drug delivery system for infusion of radioactive ray sensitizer |
| 08/05/2009 | CN201283091Y Radioactive ray sensitizer inclusion body for injection and/or infusion |
| 08/05/2009 | CN101501058A Process for preparing particles of proteinaceous material |
| 08/05/2009 | CN101501033A Novel compound having affinity for amyloid |
| 08/04/2009 | US7569673 Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors |
| 08/04/2009 | US7569536 Broad spectrum antiviral including against SARS (severe acute respiratory syndrome), DNA viruses and herpes viruses; Ser-Arg (SR), SR proteins are RNA-binding proteins; compounds are SRPK inhibitors such as 1-piperidino-2-(pyridin-4-ylcarbonylamino)-4-trifluoromethylbenzene |
| 08/04/2009 | US7569341 Nucleic acid directed immobilization arrays and methods of assembly |
| 08/04/2009 | US7569337 Labeling brain tissues in vivo or in vitro; 3-Benzothiazol-2-yl-7-[4-(2-fluoro-ethyl)-piperazin-1-yl]-chromen-2-one; diagnosis, monitoring the effectiveness of a therapeutic treatment and detecting histopathological hallmarks of Alzheimer's disease |
| 08/04/2009 | US7569208 Using carbon isotope 13C-labeled inclusion complex having cyclodextrin as host molecule and a guest molecule included to detect pancreatitis and/or pancreatic cancer |
| 07/30/2009 | WO2009092913A1 Method of radiolabelling carbon nanotubes, radiolabelled carbon nanotubes, and applications thereof |
| 07/30/2009 | WO2008070384A3 Method of preparing macromolecular contrast agents and uses thereof |
| 07/30/2009 | US20090192505 Method for cryospray ablation |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191131 Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters |
| 07/30/2009 | US20090191125 Diagnostic and Therapeutic Alkyl Piperidine/Piperazine Compounds and Process |
| 07/30/2009 | US20090191124 PDGF-RBeta BINDERS |
| 07/30/2009 | US20090191123 Novel imaging agents |
| 07/30/2009 | US20090191122 Method for purification of 225ac from irradiated 226ra-targets |
| 07/30/2009 | US20090191121 Targeting and Imaging Tumor Vasculature Using Conjugates That Bind to Aminophospholipids |
| 07/30/2009 | US20090191120 Cancerous disease modifying antibodies |
| 07/30/2009 | US20090191119 Cancerous disease modifying antibodies |
| 07/30/2009 | US20090191118 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/29/2009 | EP2081601A1 Dendrimeric platform for controlled release of drugs |
| 07/29/2009 | EP1729824B1 Phospholipid analogs for the treatment of cancers |
| 07/29/2009 | EP1641806B1 Glycerophosphocholine and its derivatives for medical imaging of neuropsychiatric disorders |
| 07/29/2009 | CN100518739C A retroviral immunotherapy |
| 07/28/2009 | US7566690 Ace inhibitory peptides from plant materials |
| 07/28/2009 | US7566442 Emulsion; nanoparticles of liquid perfluorocarbon cores coated with lipid/surfactant coupled to integrin specific ligand; 3-({7-[(imidazol-2-ylamino)methyl]-1-methyl-4-oxo(3-hydroquinolyl)}carbonylamino)propanoic Acid adduct with Distearoyl-Glycero-3-Phosphoethanolamine-(PEG)-Maleimide deriv; nonantibody |
| 07/23/2009 | WO2008118601A3 Radiolabeled affibody molecules |
| 07/23/2009 | WO2007143701A8 Monoclonal antibodies that potently neutralize hepatitis c virus (hcv) of diverse genotypes |
| 07/23/2009 | US20090186409 Compositions and methods for the diagnosis and treatment of tumor |
| 07/23/2009 | US20090186076 Combined Use of TGF-Beta Signaling Inhibitor and Antitumor Agent |
| 07/23/2009 | US20090186070 Particle immobilized coating and uses thereof |
| 07/23/2009 | US20090186036 Anti-Alpha V Beta 6 Antibodies |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090185976 Method for introducing a chemical agent into the systemic circulation |
| 07/23/2009 | US20090185974 Chimeric, Human and Humanized Anti-Granulocyte Antibodies and Methods of Use |
| 07/23/2009 | US20090185973 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 07/22/2009 | EP2081026A1 Marker for inflammatory conditions |
| 07/22/2009 | EP2080526A1 Radioactive diagnostic imaging agent |
| 07/22/2009 | EP2079486A2 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 07/22/2009 | EP1827239A4 Positron emission tomography imaging method |
| 07/22/2009 | EP1670520A4 Miniaturized 62zn/62cu generator for high concentration clinical delivery of 62cu kit formulation for the facile preparation of radiolabeled cu-bis(thiosemicarbazone) compounds |
| 07/22/2009 | EP1251877A4 Site specific binding system, nuclear imaging compositions and methods |
| 07/22/2009 | CN101485891A Radioactive nuclide marked RGD polypeptide medicament and preparation method thereof |
| 07/21/2009 | US7563439 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue; radioimmunotherapy |
| 07/21/2009 | US7563433 Methods and compositions for F-18 labeling of proteins, peptides and other molecules |
| 07/21/2009 | CA2406650C Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 07/21/2009 | CA2328528C Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 07/16/2009 | WO2009089383A2 Inhibitors of carbonic anhydrase ix |
| 07/16/2009 | WO2009089288A1 Methods and devices for minimally-invasive extraocular delivery of radiation to the posterior portion of the eye |
| 07/16/2009 | WO2009089088A1 Methods for in vivo atherosclerotic plaque characterization using magnetic susceptibility to identify symptom-producing plaques |
| 07/16/2009 | WO2009087066A2 Method for preparing a marked purine derivative, said derivative and uses thereof |
| 07/16/2009 | WO2002087497A3 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
| 07/16/2009 | US20090180956 Diagnostic for evaluating gastric evacuation function and/or small intestinal absorption function |
| 07/16/2009 | US20090180955 Methods and compositions for detection of bacteria and treatment of diseases and disorders |
| 07/16/2009 | US20090180954 Biokinetics of fast-clearing polypeptides |
| 07/16/2009 | US20090180953 Invention concerning GLP-1 and exendin |
| 07/16/2009 | US20090180952 Ligands binding the complex of urokinase-type plasminogen activator (uppa) and its receptor (upar) that inhibit downstream upar interactions: identification and use in diagnosis or therapy |
| 07/16/2009 | US20090180951 Inhibitors of integrin vla-4 |
| 07/16/2009 | US20090180950 Polychromatic, diversely-sized particles for angiography |
| 07/16/2009 | CA2714985A1 Methods and devices for minimally-invasive extraocular delivery of radiation to the posterior portion of the eye |
| 07/16/2009 | CA2711678A1 Inhibitors of carbonic anhydrase ix |
| 07/16/2009 | CA2710900A1 Method for preparing a marked purine derivative, said derivative and uses thereof |
| 07/15/2009 | EP1744758A4 Radiopharmaceutical and methods of synthesis and use thereof |
| 07/15/2009 | EP1675625A4 Mechanism-based targeted pancreatic beta cell imaging and therapy |
| 07/15/2009 | EP1507561B1 Compositions for delivering nucleic acids to cells |
| 07/15/2009 | CN101484190A Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents |
| 07/14/2009 | US7560110 Radioimmunotherapy; antibody fragment having at least one arm that specifically binds a targeted tissue and at least one other arm that specifically binds a targetable construct |
| 07/14/2009 | CA2439222C Identification of partial agonists of the a2a adenosine receptor |
| 07/09/2009 | WO2009086539A2 Treatment and prophylaxis of amyloidosis |
| 07/09/2009 | WO2009086067A2 Particles for injection and processes fo forming the same |